Developer docs
API playgroundTry for free, no card

Search company profiles

2048 Ventures

Full company profile

uuid0000a2n

Namestring
2048 Ventures
Legal namestring
2048 Ventures
Websiteurl
2048.vc
Company typeenum
Private
Founded yearint
2017
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pre-seed venture capital, seed-stage investing, early-stage funding, thesis-driven venture capital, startup lead investor
Industry2 codes
1Early-Stage Venture Capital (Pre-Seed/Seed)
CodeFSANAAAAPrimaryNo
2Early-Stage Venture Capital (Series A/B)
CodeFSANAAABPrimaryNo
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital / Early-Stage Investing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Venture Fund Management (Management Fees + Carry)
TypeManaged Services
Description

Venture capital fund management economics: 2048 Ventures raised an oversubscribed $82M Fund III (closed January/April 2026), having previously deployed Fund I and Fund II. Revenue derives from typical VC fund management fees on committed AUM and carried interest on profitable exits (e.g., Aerodome acquired by Flock Safety as a Fund II outcome). Backing comes from fund-of-funds, family offices, and executives from major technology companies.

2048.vc
2Carried Interest from Portfolio Exits
TypeLicensing Royalties
Description

Realized exits generate carry revenue; notable Fund II exit includes Aerodome's acquisition by Flock Safety, described as one of the largest acquisitions in public safety to date. Earlier exits include SPIDR Tech (Aerodome founder's prior company).

2048.vc
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details2 tiers
1Pre-Seed Fast Track: $250K–$750K lead check, target round $500K–$1.5M
ModelOtherBilling cadenceMulti-year contract
Notes

10 business days from first meeting to money in bank; SAFE preferred; 1/2 of round expected from 2048; eligible for founders raising <$2M (first round).

2048.vc
2Standard Pre-Seed/Seed Lead: $500K–$3M check
ModelOtherBilling cadenceMulti-year contract
Notes

Lead pre-seed and seed rounds; SAFE for pre-seed, priced rounds also acceptable; lead typically takes board observer seat (not board seat at pre-seed); 10–15 business days from first meeting to term sheet.

2048.vc
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

2048 Ventures is a thesis-driven early-stage venture capital firm that leads Pre-Seed and Seed investment rounds with $500K-$3M checks in startups focused on Vertical AI, Deep Tech, Health, and Bio, primarily based in NYC and Boston. The firm's signature Pre-Seed Fast Track program commits a $250K-$750K lead check within 10 business days of the first meeting via a structured five-step process (intro, deep dive, references and in-person, term sheet, wire). Capital is deployed across three successive funds, with the most recent being an oversubscribed $82M Fund III closed in January 2026.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

2048 Ventures is a thesis-driven, early-stage venture capital firm rather than a software product company. Its core 'product' is the lead-check investment it writes into Pre-Seed and Seed startups, executed through two main vehicles: the $82M oversubscribed Fund III (used for $500K-$3M checks) and the Pre-Seed Fast Track program (used for $250K-$750K checks closed within 10 business days). Around these investment products the firm bundles content/community offerings, including the 2048 Ventures Newsletter, the Startup Hacks blog, and the VC Fellows '26 cohort program. The firm's portfolio — including companies such as Rely Intelligence, Pocket, Broome AI, Nionyx Bio, Kascaid, Nimbus Health, Aslan Protects, Rondah AI, Tetsuwan Scientific, Psyrin, TwoStep Therapeutics, Century Health, Ripple, Neobe, Enurgen, Aclid, Pageport, Wareclouds, Centro Commerce, Persist AI, H2Ok Innovations (now Laminar), FemTherapeutics, Adaptis, Stabl, and Frate — represents the realized output of these investment products across Vertical AI, Deep Tech, Health, and Bio focus areas.

Product and service5 records
12048 Ventures Fund III
CategoryInvestment fund
Description

Oversubscribed $82 million fund vehicle used to lead first-check Pre-Seed and Seed investments with $500K-$3M checks in Vertical AI, Deep Tech, Healthcare, and Biotech startups primarily in NYC and Boston.

2Pre-Seed Fast Track
CategoryInvestment program
Description

Structured five-step program (intro, deep dive, references + in-person, term sheet, wire) that delivers a $250K-$750K lead check within 10 business days of the first meeting, targeted at NYC and Boston Pre-Seed founders raising under $2M in their first round, using SAFE preferred instruments.

3Startup Hacks Blog
CategoryContent / community
Description

Newsletter and blog operated by 2048 Ventures Founder and Partner Alex Iskold covering startup building topics and serving as one of the firm's flagship content offerings and founder-marketing channels.

42048 Ventures Newsletter
CategoryNewsletter / subscription offering
Description

Email newsletter distributed via Constant Contact that delivers 2048 Ventures' investments, theses, and announcements to subscribers.

5VC Fellows Program
CategoryTalent / community program
Description

Cohort-based fellowship for undergraduate and graduate students that embeds fellows directly into 2048 Ventures' investing team to identify, diligence, and source startups across Vertical AI, Deep Tech, Health, and Bio.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

2048 led Pageport's $3.3M seed round alongside Slant, an AI-powered CRM for financial advisors; co-marketing signal to financial-advisor segment.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Long-standing co-investor and sourcing partner across many portfolio companies (Aerodome, Airspace Link, Stabl, Wareclouds, Ripple, Enurgen, H2Ok); Alex Iskold was Techstars NYC Managing Director for 5 years prior to founding 2048.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Acceleration and sourcing partner — 2048 met Wareclouds founders during the CDL Supply Chain program in Montreal.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Introduced Tetsuwan founders Cristian Ponce and Theo Schafer; portfolio accelerator partner.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Alex Iskold serves as VC-in-Residence at HBS; firm sources VC Fellows and founders from HBS programs.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Alex Iskold serves on the Board at NYU Entrepreneurship; sourcing relationship from NYU's NYC founder pipeline.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Zann Ali (Partner) serves on MIT's Entrepreneurial Finance & Venture Capital teaching team; former Dorm Room Fund investor; sources VC Fellows and founders from MIT.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Julie Wolf (Partner) was previously Chief Science Officer on IndieBio NY's founding investment team; sourcing and biotech network partnership.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Daniella Cohen was previously a managing partner at Rough Draft Ventures before joining 2048 as Principal; sourcing partnership for student founders.

Strategic tierMinorTypeOthers
Description

Prior employer of Zann Ali — informs 2048's institutional/LP relationships and operating expertise.

Strategic tierMinorTypeOthers
Description

Prior employer of Zann Ali (4 years), including Fidelity Health startup launch — informs 2048's healthcare investing lens.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Acquired 2048 portfolio company Aerodome; described as one of the largest acquisitions in public safety to date. Key exit partner for 2048 Fund II.

Strategic tierMinorTypeOthers
Description

Neobe co-founder Pedro Correa de Sampaio conducted postdoctoral work at MD Anderson; informs 2048's biotech network and sourcing.

Strategic tierCoreTypeOthers
Description

TwoStep Therapeutics co-founders include Carolyn Bertozzi, Jennifer Cochran, and Ron Levy from Stanford; academic research partner for TwoStep technology.

Strategic tierCoreTypeOthers
Description

Enurgen spun out of University of Ottawa's SUNLAB, one of the most prestigious solar labs in the world; sourcing relationship.

Strategic tierCoreTypeOthers
Description

Aclid scientific co-founder Harris Wang is a Professor at Columbia University; synbio research network.

Strategic tierMinorTypeOthers
Description

Caravel Bio (2048 portfolio) received $7.8M NSF award for protein discovery platform — supports non-dilutive funding pathway for portfolio.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NYC-based pre-seed and seed VC that writes similarly sized checks into early-stage startups. Highly comparable as a NYC-focused early-stage lead investor; 2048 and BoxGroup have even co-invested (Aslan Protects).

TypeDirect peer
Description

NYC seed VC leading pre-seed and seed rounds at comparable check sizes with a thesis-driven, sector-flexible approach. One of the closest direct competitors for NYC early-stage founders.

TypeDirect peer
Description

Seed-stage VC with an East Coast footprint that leads early rounds in technology startups. 2048 has co-led deals with Founder Collective (Vitally), making it a directly comparable peer.

TypeBroad incumbent
Description

Established NYC-based seed VC with a larger fund and broader platform programs (Review, Seed Stage). Overlaps with 2048 in NYC seed-stage lead investing but at materially larger scale.

TypeDirect peer
Description

NYC and Boston-based early-stage VC investing in pre-seed and seed rounds. Repeated co-investor with 2048 (H2Ok Innovations / Laminar), making it a directly comparable peer in NYC/Boston seed investing.

TypeBroad incumbent
Description

NYC-based venture firm investing across stages with strong NYC presence and consumer/enterprise breadth. Has led Series A rounds for 2048 portfolio companies (Laminar).

TypeDirect peer
Description

NYC-based pre-seed and seed fund focused on early-stage startups with thesis-driven investing. Comparable as a NYC thesis-led micro/seed fund.

TypeDirect peer
Description

NYC-based early-stage VC writing pre-seed and seed checks into diverse founding teams. Comparable as a NYC-led pre-seed/seed investor with a community-oriented sourcing approach.

TypeBroad incumbent
Description

Global accelerator network; Alex Iskold was Techstars NYC MD for 5 years and 2048 has co-invested with Techstars in multiple portfolio companies (Aerodome, Airspace Link, Stabl, Ripple, Enurgen, H2Ok). Comparable as an early-stage capital and sourcing partner.

TypeEmerging player
Description

Student-led pre-seed fund; multiple 2048 team members (Zann Ali, Daniella Cohen, Edward Jin) were former Dorm Room Fund investors. Comparable as a campus-embedded pre-seed sourcing channel.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment178 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

2048 Ventures

Venture Capital / Early-Stage Investing2048.vc

2048 Ventures firmographics

Firmographics
Name
2048 Ventures
Legal name
2048 Ventures
Website
https://2048.vc
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where 2048 Ventures is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

2048 Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Venture Fund Management (Management Fees + Carry): Venture capital fund management economics: 2048 Ventures raised an oversubscribed $82M Fund III (closed January/April 2026), having previously deployed Fund I and Fund II. Revenue derives from typical VC fund management fees on committed AUM and carried interest on profitable exits (e.g., Aerodome acquired by Flock Safety as a Fund II outcome). Backing comes from fund-of-funds, family offices, and executives from major technology companies.
  2. Carried Interest from Portfolio Exits: Realized exits generate carry revenue; notable Fund II exit includes Aerodome's acquisition by Flock Safety, described as one of the largest acquisitions in public safety to date. Earlier exits include SPIDR Tech (Aerodome founder's prior company).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPre-Seed Fast Track: $250K–$750K lead check, target round $500K–$1.5M
OtherMulti-year contractStandard Pre-Seed/Seed Lead: $500K–$3M check

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

2048 Ventures product offering

Product offering

Core offering

2048 Ventures is a thesis-driven early-stage venture capital firm that leads Pre-Seed and Seed investment rounds with $500K-$3M checks in startups focused on Vertical AI, Deep Tech, Health, and Bio, primarily based in NYC and Boston. The firm's signature Pre-Seed Fast Track program commits a $250K-$750K lead check within 10 business days of the first meeting via a structured five-step process (intro, deep dive, references and in-person, term sheet, wire). Capital is deployed across three successive funds, with the most recent being an oversubscribed $82M Fund III closed in January 2026.

Product overview

2048 Ventures is a thesis-driven, early-stage venture capital firm rather than a software product company. Its core 'product' is the lead-check investment it writes into Pre-Seed and Seed startups, executed through two main vehicles: the $82M oversubscribed Fund III (used for $500K-$3M checks) and the Pre-Seed Fast Track program (used for $250K-$750K checks closed within 10 business days). Around these investment products the firm bundles content/community offerings, including the 2048 Ventures Newsletter, the Startup Hacks blog, and the VC Fellows '26 cohort program. The firm's portfolio — including companies such as Rely Intelligence, Pocket, Broome AI, Nionyx Bio, Kascaid, Nimbus Health, Aslan Protects, Rondah AI, Tetsuwan Scientific, Psyrin, TwoStep Therapeutics, Century Health, Ripple, Neobe, Enurgen, Aclid, Pageport, Wareclouds, Centro Commerce, Persist AI, H2Ok Innovations (now Laminar), FemTherapeutics, Adaptis, Stabl, and Frate — represents the realized output of these investment products across Vertical AI, Deep Tech, Health, and Bio focus areas.

Differentiator

Problem solved

Functional benefit

Products and services

  • 2048 Ventures Fund III Oversubscribed $82 million fund vehicle used to lead first-check Pre-Seed and Seed investments with $500K-$3M checks in Vertical AI, Deep Tech, Healthcare, and Biotech startups primarily in NYC and Boston.
  • Pre-Seed Fast Track Structured five-step program (intro, deep dive, references + in-person, term sheet, wire) that delivers a $250K-$750K lead check within 10 business days of the first meeting, targeted at NYC and Boston Pre-Seed founders raising under $2M in their first round, using SAFE preferred instruments.
  • Startup Hacks Blog Newsletter and blog operated by 2048 Ventures Founder and Partner Alex Iskold covering startup building topics and serving as one of the firm's flagship content offerings and founder-marketing channels.
  • 2048 Ventures Newsletter Email newsletter distributed via Constant Contact that delivers 2048 Ventures' investments, theses, and announcements to subscribers.
  • VC Fellows Program Cohort-based fellowship for undergraduate and graduate students that embeds fellows directly into 2048 Ventures' investing team to identify, diligence, and source startups across Vertical AI, Deep Tech, Health, and Bio.

Companies that use 2048 Ventures

Customer profile

Named customers21 records

Ideal customer profiles1 record

2048 Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

2048 Ventures partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered minor, flagship and core.

  • Pageport (Slant / AI CRM)minorGTM or Marketing Partner2048 led Pageport's $3.3M seed round alongside Slant, an AI-powered CRM for financial advisors; co-marketing signal to financial-advisor segment.
  • TechstarsflagshipStrategic or Co-development PartnerLong-standing co-investor and sourcing partner across many portfolio companies (Aerodome, Airspace Link, Stabl, Wareclouds, Ripple, Enurgen, H2Ok); Alex Iskold was Techstars NYC Managing Director for 5 years prior to founding 2048.
  • Creative Destruction Lab (CDL) Supply ChaincoreStrategic or Co-development PartnerAcceleration and sourcing partner — 2048 met Wareclouds founders during the CDL Supply Chain program in Montreal.
  • Entrepreneur FirstcoreStrategic or Co-development PartnerIntroduced Tetsuwan founders Cristian Ponce and Theo Schafer; portfolio accelerator partner.
  • Harvard Business School (HBS)flagshipStrategic or Co-development PartnerAlex Iskold serves as VC-in-Residence at HBS; firm sources VC Fellows and founders from HBS programs.
  • NYU EntrepreneurshipflagshipStrategic or Co-development PartnerAlex Iskold serves on the Board at NYU Entrepreneurship; sourcing relationship from NYU's NYC founder pipeline.
  • MIT Sloan School of ManagementflagshipStrategic or Co-development PartnerZann Ali (Partner) serves on MIT's Entrepreneurial Finance & Venture Capital teaching team; former Dorm Room Fund investor; sources VC Fellows and founders from MIT.
  • SOSV IndieBiocoreStrategic or Co-development PartnerJulie Wolf (Partner) was previously Chief Science Officer on IndieBio NY's founding investment team; sourcing and biotech network partnership.
  • Rough Draft VenturesminorStrategic or Co-development PartnerDaniella Cohen was previously a managing partner at Rough Draft Ventures before joining 2048 as Principal; sourcing partnership for student founders.
  • Putnam InvestmentsminorOthersPrior employer of Zann Ali — informs 2048's institutional/LP relationships and operating expertise.
  • Fidelity InvestmentsminorOthersPrior employer of Zann Ali (4 years), including Fidelity Health startup launch — informs 2048's healthcare investing lens.
  • Flock SafetyflagshipStrategic or Co-development PartnerAcquired 2048 portfolio company Aerodome; described as one of the largest acquisitions in public safety to date. Key exit partner for 2048 Fund II.
  • MD Anderson Cancer CenterminorOthersNeobe co-founder Pedro Correa de Sampaio conducted postdoctoral work at MD Anderson; informs 2048's biotech network and sourcing.
  • Stanford University (Bertozzi, Cochran, Levy Labs)coreOthersTwoStep Therapeutics co-founders include Carolyn Bertozzi, Jennifer Cochran, and Ron Levy from Stanford; academic research partner for TwoStep technology.
  • University of Ottawa SUNLABcoreOthersEnurgen spun out of University of Ottawa's SUNLAB, one of the most prestigious solar labs in the world; sourcing relationship.
  • Columbia University (Harris Wang lab)coreOthersAclid scientific co-founder Harris Wang is a Professor at Columbia University; synbio research network.
  • NIH / US National Science FoundationminorOthersCaravel Bio (2048 portfolio) received $7.8M NSF award for protein discovery platform — supports non-dilutive funding pathway for portfolio.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

2048 Ventures competitors and assessment

Company assessment

Direct peers

  • BoxGroup: NYC-based pre-seed and seed VC that writes similarly sized checks into early-stage startups. Highly comparable as a NYC-focused early-stage lead investor; 2048 and BoxGroup have even co-invested (Aslan Protects).
  • Lerer Hippeau: NYC seed VC leading pre-seed and seed rounds at comparable check sizes with a thesis-driven, sector-flexible approach. One of the closest direct competitors for NYC early-stage founders.
  • Founder Collective: Seed-stage VC with an East Coast footprint that leads early rounds in technology startups. 2048 has co-led deals with Founder Collective (Vitally), making it a directly comparable peer.
  • Flybridge: NYC and Boston-based early-stage VC investing in pre-seed and seed rounds. Repeated co-investor with 2048 (H2Ok Innovations / Laminar), making it a directly comparable peer in NYC/Boston seed investing.
  • Female Founders Fund: NYC-based pre-seed and seed fund focused on early-stage startups with thesis-driven investing. Comparable as a NYC thesis-led micro/seed fund.
  • Harlem Capital: NYC-based early-stage VC writing pre-seed and seed checks into diverse founding teams. Comparable as a NYC-led pre-seed/seed investor with a community-oriented sourcing approach.

Broad incumbents

  • First Round Capital: Established NYC-based seed VC with a larger fund and broader platform programs (Review, Seed Stage). Overlaps with 2048 in NYC seed-stage lead investing but at materially larger scale.
  • Greycroft: NYC-based venture firm investing across stages with strong NYC presence and consumer/enterprise breadth. Has led Series A rounds for 2048 portfolio companies (Laminar).
  • Techstars: Global accelerator network; Alex Iskold was Techstars NYC MD for 5 years and 2048 has co-invested with Techstars in multiple portfolio companies (Aerodome, Airspace Link, Stabl, Ripple, Enurgen, H2Ok). Comparable as an early-stage capital and sourcing partner.

Emerging players

  • Dorm Room Fund: Student-led pre-seed fund; multiple 2048 team members (Zann Ali, Daniella Cohen, Edward Jin) were former Dorm Room Fund investors. Comparable as a campus-embedded pre-seed sourcing channel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

2048 Ventures social profiles

Digital presence

2048 Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

2048 Ventures leadership team

Management profile

Number of profiles

Profiles4 records

2048 Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

2048 Ventures M&A and investment

M&A and investment

M&A

Investments178 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 2048 Ventures

What does 2048 Ventures do?

2048 Ventures is a thesis-driven early-stage venture capital firm that leads Pre-Seed and Seed investment rounds with $500K-$3M checks in startups focused on Vertical AI, Deep Tech, Health, and Bio, primarily based in NYC and Boston. The firm's signature Pre-Seed Fast Track program commits a $250K-$750K lead check within 10 business days of the first meeting via a structured five-step process (intro, deep dive, references and in-person, term sheet, wire). Capital is deployed across three successive funds, with the most recent being an oversubscribed $82M Fund III closed in January 2026.

Is 2048 Ventures a public or private company?

2048 Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was 2048 Ventures founded?

2048 Ventures was founded in 2017. It employs 1 to 10 people.

Where is 2048 Ventures based?

2048 Ventures is headquartered in New York, United States, in the North America region.

How does 2048 Ventures make money?

Two revenue lines are on record. Venture Fund Management (Management Fees + Carry) is the primary driver. The others are carried Interest from Portfolio Exits.

Who are 2048 Ventures's main competitors?

Direct peers on record are BoxGroup, Lerer Hippeau, Founder Collective, Flybridge, Female Founders Fund and Harlem Capital. Broad incumbents are First Round Capital, Greycroft and Techstars. Dorm Room Fund is listed as an emerging player.

Does 2048 Ventures have an API?

No public API is recorded for 2048 Ventures.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Zeroset Raises $5.2 Million Pre-Seed Round Co-Led By Gradient And 2048 VenturesZeroset raised $5.2 million in pre-seed funding co-led by Gradient and 2048 Ventures. The company is developing Nebula, a system to capture operational state and traces for enterprise AI agents. Nebula is in closed research preview, with the company aiming to create enterprise "worlds" for AI to learn from company operations.SynBioBetaTwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug ConjugateTwoStep Therapeutics announced an oversubscribed $62.5 million Series A financing and FDA clearance of its IND for TS-104, a first-in-class peptide-drug conjugate. The financing, led by Insight Partners and Medical Excellence Capital, brings total capital to $71.2 million. Patient enrollment for the Phase 1 trial is expected later this year.BioSpaceTwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug ConjugateTwoStep Therapeutics announced an oversubscribed $62.5 million Series A financing and FDA clearance of its IND for TS-104, a peptide-drug conjugate. The financing brings total capital to $71.2 million, enabling a first-in-human Phase 1 trial with enrollment expected later this year.Tech.euNebex launches €100M initiative to turn global space spending into revenue for French startupsNebex launched a €100 million initiative in France to turn cross-border space spending into domestic revenue for startups. The model promises €1 of industrial return for every €1 spent abroad, matching government demand with French suppliers. The company plans to replicate the initiative across Europe.Tech Funding NewsTwin sisters from Princeton and Goldman Sachs raise $44M at $1.15B valuation for wellness unicorn Genius AI — TFNGenius AI, formerly GlossGenius, has raised $44 million in Series D funding at a $1.15 billion valuation, becoming a unicorn. The round was led by Lux Capital with participation from Bessemer Venture Partners, Imaginary Ventures, L Catterton Growth, 2048 Ventures, and StepStone Private Ventures. The company, founded by twin sisters who left Goldman Sachs, serves over 125,000 service businesses across half of all US ZIP codes and is approaching a $200 million annual revenue run rate, while rebranding to reflect its expansion from beauty and wellness software into AI agents for the broader in-person service economy.Venture Capital Access OnlineIntroducing Genius AI: The Company Behind GlossGenius Raises Series D at a $1.15 Billion ValuationGenius AI raised $44 million in Series D financing at a $1.15 billion valuation, led by Lux Capital. The company, formerly GlossGenius, now serves over 125,000 U.S. businesses and estimates saving 112 million hours of administrative work. It is approaching a $200 million revenue run-rate.The Next WebNebex raises $30M from GV to build a space exchangeNebex raised $30M in a seed round led by GV to build a space exchange connecting firms, governments, and investors. The platform targets deals of $100M or more, aiming to streamline cross-border payments. A preliminary site is due later this summer, with a full launch planned by year-end.TechStartupsSwiss neurotech startup Neurosoft raises $7.5M to build AI-powered stretchable brain-computer interfacesSwiss neurotech startup Neurosoft raised $7.5M in a seed round led by Skybound Venture Capital to develop stretchable brain-computer interfaces. The electrodes are up to 1,000 times more compliant than existing flexible interfaces and have been tested in 10 patients. The company aims to commercialize its first product in the U.S. and build a neural data platform.TechStartupsVenture Capital & Startup Funding Roundup, May 20, 2026On May 20, 2026, multiple startups raised capital, including Mercury's $200M Series D at a $5.2B valuation and Exa's $250M Series C at $2.2B. Other rounds included Hardline's $2M pre-seed and Rely's $4.5M seed, reflecting a shift toward verticalized AI applications.TechStartupsReal and iExec partner to solve privacy challenges in institutional RWA marketsReal and iExec signed a memorandum of understanding to explore confidential computing for tokenized real-world asset operations. The partnership will evaluate how iExec's Nox Protocol can integrate with Real's Layer 1 blockchain to support private financial workflows while maintaining compliance and auditability. The collaboration is not a commercial deployment; the next phase will focus on technical discussions and pilot opportunities.